Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Prognostic characteristics of malignant pleural mesothelioma

Muzaffer Metintaş, Guntulu Ak, Selma Metintas
European Respiratory Journal 2017 50: PA1592; DOI: 10.1183/1393003.congress-2017.PA1592
Muzaffer Metintaş
Eskisehir Osmangazi University, Lung and Pleural Cancers Research and Clinical Center, Eskisehir, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guntulu Ak
Eskisehir Osmangazi University, Lung and Pleural Cancers Research and Clinical Center, Eskisehir, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Selma Metintas
Eskisehir Osmangazi University, Lung and Pleural Cancers Research and Clinical Center, Eskisehir, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Objective: To determine prognostic factors in malignant pleural mesothelioma.

Method: Variables analyzed include age at diagnosis, gender, smoking, chest pain, dyspnea, weight loss, platelet count, WBC, hemoglobin, lactate dehydrogenase, histology, stage, KPS, side of diseases, pleural fluid, treatment, talc pleurodesis, and co-morbidities. Overall survival was defined as the time between the initial diagnosis date and either date of death or last follow-up. Univariate analyses of survival in relation to patient’s demographics and tumor characteristics were conducted. The independent contribution to survival of several prognostic factors was analyzed with multivariate regression methods based on the Cox proportional hazards model.

Results: 600 patients with pathologically proven malignant pleural mesothelioma were evaluated between January 1990 and December 2016. 45 patients were excluded. Survival characteristics of 550 patients were evaluated. The mean age of the patients was 61.8±11.4 years for males and 60.1±12.2 for females (p=0.010). A total 54.4% of the cases were male and 45.6% were female. At univariate analysis, predictors of survival were age, gender, weight loss, platelet count, WBC, lactate dehydrogenase, histology, stage, KPS, side of disease, and treatment. At multivariate analysis, independent significant predictors of survival were WBC, histology, stage, KPS, and treatment. WBC≤8600, epiteloid histology, stage I–II, KPS≥80, and bi/trimodal treatment were related good prognosis in mesothelioma.

Conclusion: Mesothelioma patients with epiteloid histology, early stage disease, and good performance status should be encouraged for bi/trimodal treatment.

  • Copyright ©the authors 2017
Previous
Back to top
Vol 50 Issue suppl 61 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic characteristics of malignant pleural mesothelioma
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prognostic characteristics of malignant pleural mesothelioma
Muzaffer Metintaş, Guntulu Ak, Selma Metintas
European Respiratory Journal Sep 2017, 50 (suppl 61) PA1592; DOI: 10.1183/1393003.congress-2017.PA1592

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Prognostic characteristics of malignant pleural mesothelioma
Muzaffer Metintaş, Guntulu Ak, Selma Metintas
European Respiratory Journal Sep 2017, 50 (suppl 61) PA1592; DOI: 10.1183/1393003.congress-2017.PA1592
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Modified Glasgow Prognostic Score – a predictor of survival in malignant pleural effusion
  • Subclinical myasthenia gravis in thymomas
  • Variation in outcomes for M1a Stage Lung cacers- Outcome in Malingnat Pleural Effusion significantly worse than patients with Contralateral Lung Nodules
Show more Pleural and mediastinal malignancies

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society